The COVID-19 Effect: Medicare Part B Oncology Drug Claims Down 40% Through April

 
• By Cathy Kelly
  
Infusion of a hospital
Physician Administration Of Infused Drugs Down Sharply

More from Market Access

More from Pink Sheet